A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations  Ian E. Bosdet, T. Roderick.

Slides:



Advertisements
Similar presentations
Martina I. Lefterova, Peidong Shen, Justin I
Advertisements

Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon- Based Massive Parallel Pyrosequencing  Geneviève Michils, Silke Hollants,
Ane Y. Schmidt, Thomas v. O. Hansen, Lise B
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens  David H. Spencer, Jennifer K. Sehn,
Implementation of a Reliable Next-Generation Sequencing Strategy for Molecular Diagnosis of Dystrophinopathies  Melissa Alame, Delphine Lacourt, Reda.
Carol Beadling, Tanaya L. Neff, Michael C
A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens  Iris Babion, Barbara C. Snoek,
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Martina I. Lefterova, Peidong Shen, Justin I
Emily M. Kudalkar, Naif A. M
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
In Silico Proficiency Testing for Clinical Next-Generation Sequencing
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes  Paula Paulo, Pedro.
Methodologic Considerations in the Application of Next-Generation Sequencing of Human TRB Repertoires for Clinical Use  Liwen Xu, Xiaoqing You, PingPing.
Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data  David H. Spencer,
Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin- Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens  Andrew.
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications  Vera Grossmann, Andreas Roller, Hans-Ulrich Klein, Sandra Weissmann,
Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing  Eric T. Weimer, Maureen Montgomery, Rosanne.
False Positives in Multiplex PCR-Based Next-Generation Sequencing Have Unique Signatures  Chad M. McCall, Stacy Mosier, Michele Thiess, Marija Debeljak,
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing  Jean-Marc Rey, Vincent Ducros, Pascal.
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Angela Leo, Andrew M. Walker, Matthew S
Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays 
Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next- Generation Sequencing Assays  David J. Sims, Robin D. Harrington,
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management 
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival  Ryan K. Van Laar 
Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L
A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2  Jianli Li, Hongzheng Dai, Yanming Feng, Jia Tang, Stella Chen,
Jennifer Kerkhof, Laila C
A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families  Wenhui L.
Rapid Molecular Profiling of Myeloproliferative Neoplasms Using Targeted Exon Resequencing of 86 Genes Involved in JAK-STAT Signaling and Epigenetic Regulation 
Eric Samorodnitsky, Jharna Datta, Benjamin M
Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs , ABCB11 rs , and RNF7 rs Genotypes in Chronic.
Catherine E. Cottrell, Hussam Al-Kateb, Andrew J. Bredemeyer, Eric J
ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing  Colin C. Pritchard, Christina Smith,
Improved Heritability Estimation from Genome-wide SNPs
Rapid Detection of TEM-Type Extended-Spectrum β-Lactamase (ESBL) Mutations Using Lights-On/Lights-Off Probes with Single-Stranded DNA Amplification  Kenneth.
Hilmi Ozcelik, Xuejiang Shi, Martin C
Molecular Analysis of the Breast Cancer Genes BRCA1 and BRCA2 Using Amplicon- Based Massive Parallel Pyrosequencing  Geneviève Michils, Silke Hollants,
SNPitty The Journal of Molecular Diagnostics
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer  Kazimierz.
Detection of Mutations in Myeloid Malignancies through Paired-Sample Analysis of Microdroplet-PCR Deep Sequencing Data  Donavan T. Cheng, Janice Cheng,
Utility of NIST Whole-Genome Reference Materials for the Technical Validation of a Multigene Next-Generation Sequencing Test  Bennett O.V. Shum, Ilya.
Olivier Gruselle, Thierry Coche, Jamila Louahed 
Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine  Seokhwi Kim, Charny Park, Yongick Ji, Deok G.
Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next- Generation Sequencing Panel Testing  Wenbo Mu, Hsiao-Mei Lu, Jefferey.
Multiplexed High Resolution Melting Assay for Versatile Sample Tracking in a Diagnostic and Research Setting  Céline Helsmoortel, R. Frank Kooy, Geert.
Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT.
External Quality Assessment for Detection of Fetal Trisomy 21, 18, and 13 by Massively Parallel Sequencing in Clinical Laboratories  Rui Zhang, Hongyun.
A Variant Detection Pipeline for Inherited Cardiomyopathy–Associated Genes Using Next-Generation Sequencing  Théo G.M. Oliveira, Miguel Mitne-Neto, Louise.
Defining Ploidy-Specific Thresholds in Array Comparative Genomic Hybridization to Improve the Sensitivity of Detection of Single Copy Alterations in Cell.
DNA and RNA References for qRT-PCR Assays in Exfoliated Cervical Cells
Volume 26, Issue 5, Pages (March 2016)
Dale Muzzey, Shera Kash, Jillian I. Johnson, Laura M
Validation for Clinical Use of, and Initial Clinical Experience with, a Novel Approach to Population-Based Carrier Screening using High-Throughput, Next-Generation.
Strategy for Robust Detection of Insertions, Deletions, and Point Mutations in CEBPA, a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing.
A Pyrosequencing-Based Assay for the Rapid Detection of the 22q11
Custom Design of a GeXP Multiplexed Assay Used to Assess Expression Profiles of Inflammatory Gene Targets in Normal Colon, Polyp, and Tumor Tissue  Janice.
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay  Thomas.
Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell- Free Tumor DNA Measurements  Hua-Jun He, Erica V. Stein, Yves Konigshofer,
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA  Justin T. Brown, Ion J. Beldorth,
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Presentation transcript:

A Clinically Validated Diagnostic Second-Generation Sequencing Assay for Detection of Hereditary BRCA1 and BRCA2 Mutations  Ian E. Bosdet, T. Roderick Docking, Yaron S. Butterfield, Andrew J. Mungall, Thomas Zeng, Robin J. Coope, Erika Yorida, Katie Chow, Miruna Bala, Sean S. Young, Martin Hirst, Inanc Birol, Richard A. Moore, Steven J. Jones, Marco A. Marra, Rob Holt, Aly Karsan  The Journal of Molecular Diagnostics  Volume 15, Issue 6, Pages 796-809 (November 2013) DOI: 10.1016/j.jmoldx.2013.07.004 Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Distribution of sequencing reads in a single sample pool. The number of sequence reads generated for each sample in the pool 1A is expressed as the number that pass or fail the primary quality filter (prealignment) and the number that align on the target or to some off-target position within the human genome (postalignment). The horizontal lines indicate the minimum number of reads required for the lane to pass quality control. The Journal of Molecular Diagnostics 2013 15, 796-809DOI: (10.1016/j.jmoldx.2013.07.004) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Effect of library construction methods on the distribution of on-target sequence depth in sample pools. Data are from the shear-only (pool 1A, dark gray) and concatenate–shear (pool 1B, light gray) methods and show the distribution of all aligned sequences for each sample (A) and a set of data normalized by downsampling to 1 million on-target alignments per sample (B). The concatenate–shear method provides a more narrow distribution of coverage depths and a slightly higher median depth per sample. Boxplots indicate the distribution of high-quality sequence depth across the target region in each sample; the box spans the middle quartiles, the horizontal line indicates the median, whiskers indicate 1.5× the interquartile range, and circles indicate outliers. The Journal of Molecular Diagnostics 2013 15, 796-809DOI: (10.1016/j.jmoldx.2013.07.004) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Amplicon-specific differences in the distribution of sequence depth. A: The distribution of high-quality sequence depth at each base of each amplicon from a single sample (sample 59 in Supplemental Table S2). B: Boxplots indicate the distribution of the median high-quality sequence coverage for each sample in the pool 1A library; the box spans the middle quartiles, the horizontal line indicates the median, whiskers indicate 1.5× the interquartile range, and circles indicate outliers. The Journal of Molecular Diagnostics 2013 15, 796-809DOI: (10.1016/j.jmoldx.2013.07.004) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Alternate allele frequencies. For each sample pool (1A, 1B, 2A, and 2B), the ratio of high-quality reference bases to high-quality nonreference bases at every position in each sample is displayed. Known variants (blue) are found at values close to 1.0 (homozygous) or 0.5 (heterozygous), whereas nonvariant positions (green) have alternate allele ratios close to zero indicating the presence of very few nonreference bases at these positions. Known heterozygous small insertion and deletion positions (red) are found close to 0.5, as expected. A small number of positions with low-quality nonreference positions (purple) are common between multiple samples, but are correctly discarded by the variant prediction software. The Journal of Molecular Diagnostics 2013 15, 796-809DOI: (10.1016/j.jmoldx.2013.07.004) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 5 Estimation of minimum required sequence depth. Simulations of low sequence coverage were performed by random downsampling of data from the 1A sample pool using eight final sequencing depths and 1000 replicates for all 24 patients, followed by variant prediction. A: High-quality coverage depth is plotted against on-target alignments for all nonvariant positions (range, gray band; median, solid line), all true-positive predictions (green), all false-positive predictions (blue), and all false-negative predictions (red); error bars indicate means ± SD of each estimate. Horizontal and vertical dashed lines indicate the 100-fold sequence depth and 1 × 105 on-target alignments thresholds, respectively. B: Only false-positive and false-negative predictions. C: Per-replicate count of false-positive and false-negative predictions plotted against the number of on-target alignments. False-positive and false-negative predictions are not observed at positions with greater than 100-fold coverage or when on-target alignments for the sample exceed 100,000, and these values are used for the minimum sequence data required at each position and for each sample, respectively. The Journal of Molecular Diagnostics 2013 15, 796-809DOI: (10.1016/j.jmoldx.2013.07.004) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions